These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 3904429

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Aluminum-related osteomalacia in renal-failure patients.
    Vick KE, Johnson CA.
    Clin Pharm; 1985; 4(4):434-9. PubMed ID: 3899471
    [Abstract] [Full Text] [Related]

  • 3. Deferoxamine therapy of bone aluminum accumulation in renal dialysis patients.
    Nutr Rev; 1985 Apr; 43(4):103-5. PubMed ID: 3923410
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Do serum aluminum levels reflect underlying skeletal aluminum accumulation and bone histology before or after chelation by deferoxamine?
    Hodsman AB, Hood SA, Brown P, Cordy PE.
    J Lab Clin Med; 1985 Dec; 106(6):674-81. PubMed ID: 4067379
    [Abstract] [Full Text] [Related]

  • 6. [Osteomalacia induced by aluminum in a patient under chronic hemodialysis: successful treatment with desferrioxamine].
    Espinoza O, Gehrung E, Roessler E, Katz E, Pérez A, Delmastro J.
    Rev Med Chil; 1986 Sep; 114(9):867-71. PubMed ID: 3575972
    [No Abstract] [Full Text] [Related]

  • 7. Changes in bone histology after treatment with desferrioxamine.
    Ott SM, Andress DL, Nebeker HG, Milliner DS, Maloney NA, Coburn JW, Sherrard DJ.
    Kidney Int Suppl; 1986 Feb; 18():S108-13. PubMed ID: 3457986
    [No Abstract] [Full Text] [Related]

  • 8. Osteomalacia and bone disease arising from aluminum.
    Coburn JW, Norris KC, Nebeker HG.
    Semin Nephrol; 1986 Mar; 6(1):68-89. PubMed ID: 3110896
    [No Abstract] [Full Text] [Related]

  • 9. Precipitation of dialysis dementia by deferoxamine treatment of aluminum-related bone disease.
    Sherrard DJ, Walker JV, Boykin JL.
    Am J Kidney Dis; 1988 Aug; 12(2):126-30. PubMed ID: 3400633
    [Abstract] [Full Text] [Related]

  • 10. Fracture healing with deferoxamine therapy in a patient with aluminum-associated osteomalacia.
    Phelps KR, Einhorn TA, Vigorita VJ, Lundin AP, Friedman EA.
    ASAIO Trans; 1986 Aug; 32(1):198-200. PubMed ID: 3778712
    [No Abstract] [Full Text] [Related]

  • 11. Intraperitoneal deferoxamine therapy for aluminum intoxication in a child undergoing continuous ambulatory peritoneal dialysis.
    Andreoli SP, Dunn D, DeMyer W, Sherrard DJ, Bergstein JM.
    J Pediatr; 1985 Nov; 107(5):760-3. PubMed ID: 3932629
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clearance of aluminum by hemodialysis: effect of desferrioxamine.
    Milliner DS, Hercz G, Miller JH, Shinaberger JH, Nissenson AR, Coburn JW.
    Kidney Int Suppl; 1986 Feb; 18():S100-3. PubMed ID: 3457984
    [No Abstract] [Full Text] [Related]

  • 14. Risk factors in aluminum toxicity in children with chronic renal failure.
    Santos F, Massie MD, Chan JC.
    Nephron; 1986 Feb; 42(3):189-95. PubMed ID: 3511396
    [No Abstract] [Full Text] [Related]

  • 15. Aluminum intoxication of bone in renal failure--fact or fiction?
    Malluche HH, Faugere MC, Smith AJ, Friedler RM.
    Kidney Int Suppl; 1986 Feb; 18():S70-3. PubMed ID: 3458000
    [No Abstract] [Full Text] [Related]

  • 16. [Aluminum-induced osteomalacia in chronic hemodialysis].
    Smetana S, Popovtzer MM, Bar-Khayim Y.
    Harefuah; 1987 Jun 15; 112(12):595-7. PubMed ID: 3428727
    [No Abstract] [Full Text] [Related]

  • 17. Aluminum and phosphate: the double bind.
    Kaye M, Gagnon R.
    Am J Kidney Dis; 1985 Nov 15; 6(5):365-7. PubMed ID: 3904430
    [No Abstract] [Full Text] [Related]

  • 18. Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity.
    Sprague SM, Corwin HL, Wilson RS, Mayor GH, Tanner CM.
    Arch Intern Med; 1986 Oct 15; 146(10):2063-4. PubMed ID: 3767553
    [Abstract] [Full Text] [Related]

  • 19. Improved bone formation in dialysis patients after substitution of calcium carbonate for aluminum gels.
    Hercz G, Andress DL, Norris KC, Shinaberger JH, Slatopolsky EA, Sherrard DJ, Coburn JW.
    Trans Assoc Am Physicians; 1987 Oct 15; 100():139-46. PubMed ID: 3455064
    [No Abstract] [Full Text] [Related]

  • 20. Aluminum-related osteomalacia: clinical and histological improvement following treatment with desferrioxamine (DFO).
    Rapoport J, Chaimovitz C, Abulfil A, Mostovlavsky M, Gazit D, Bab I.
    Isr J Med Sci; 1987 Dec 15; 23(12):1242-6. PubMed ID: 3440748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.